Among the benefits of semaglutide, the GLP-1 receptor agonist may protect against heart failure events in patients with type 2 diabetes and CKD.

Comorbid diabetes was linked to worse functional and mortality outcomes, including maximum oxygen consumption, among patients with heart failure.

There are clinical benefits up to 1 year following endovascular thrombectomy for treatment of acute basilar artery occlusion.

Normoglycemic individuals spent 87% of their daily time in in the “tight range” of glucose levels (70-140 mg/dL) and the remainder above 140 mg/dL.

There is increased risk of developing hypertension in patients with self-reported snoring and excessive daytime sleepiness.